Sampo Group’s annual reporting for 2021
SAMPO PLC ANNUAL FINANCIAL REPORT 5 April 2022 at 9:30 am
Sampo Group’s annual reporting for 2021
Sampo has published its annual reporting documents for 2021 at www.sampo.com/year2021 .
For the second time, the Board of Directors’ Report and Financial Statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements. The format is Extensible Hypertext Markup Language (XHTML), and the primary statements have been labelled with XBRL tags.
The firm of authorised public accountants Deloitte Ltd has provided an independent auditor’s reasonable assurance report on Sampo’s ESEF Financial Statements in accordance with ISAE 3000 (revised).
In addition to the Board of Directors’ Report and Financial Statements, the following reviews and reports for the year 2021 are available at the same address:
- Group CEO’s Review by Torbjörn Magnusson
- Video reviews with the executive management
- Risk Management Report
- Corporate Governance Statement
- Annual Reports of Sampo plc’s subsidiaries If P&C, Topdanmark and Mandatum
- Sustainability Reports of If P&C, Topdanmark, Hastings and Mandatum
Sampo plc’s Remuneration Report for Governing Bodies was published on 28 February 2022. The report is available at the same address with the annual reporting documents.
The XHTML and PDF files of Sampo’s Board of Directors’ Report and Financial Statements and the Corporate Governance Statement are attached to this release.
Sampo will publish non-financial information in accordance with Chapter 3a, Section 5 of the Accounting Act. The Sustainability Report, including the EU Taxonomy disclosures, will be published in May 2022. Sampo will also publish its Solvency and Financial Conditions Report in May 2022.
SAMPO PLC
Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030
Distribution:
Nasdaq Helsinki
London Stock Exchange
The principal media
Financial Supervisory Authority
www.sampo.com
Attachments
- 743700UF3RL386WIDA22-2021-12-31-en
- Sampo's Board of Directors Report and Financial Statement
- Sampo's Corporate Governance Statement
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
GXO Releases Preliminary First Quarter 2024 Results24.4.2024 13:00:00 CEST | Press release
Company reiterates 2024 guidance; updates long-term financial targets GREENWICH, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced selected preliminary financial results for the quarter ended March 31, 2024. The company also reiterated its outlook for the full year 2024 on a standalone basis, updated the full-year 2024 guidance to include the expected impact of the Wincanton acquisition and revised its 2027 financial targets in advance of its first quarter 2024 earnings announcement and conference call. Malcolm Wilson, Chief Executive Officer of GXO, said, “Our solid preliminary first quarter results reflect the improving trend we noted earlier this year, and we anticipate continued sequential organic growth throughout 2024. As a result, we are reiterating our full-year 2024 guidance. “Our pace of new business wins is accelerating, with a 55% increase year over year in first quarter wins
Satellite Applications Catapult trials Arqit Network Secure™24.4.2024 13:00:00 CEST | Press release
LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, today announced the successful trial deployment of Arqit’s Network Secure product by the Satellite Applications Catapult which works across the space sector to make use of and benefit from satellite technologies. The satellite sector is strategically important with long lived sensitive data and so is a prime target for intellectual property theft. Satellite sector organisations must ensure they are safe from both current and future cyber threats including from quantum computing. Nation states and cyber adversaries are known to be deploying “store-now, decrypt-later” attacks, stockpiling encrypted data to decrypt it with the advent of quantum computing. There is an urgent need to harden encryption for network infrastructure today both for users transmitting data over satellite infrastructure as well as for the multitude of organisations in the supply chain th
ATHA Energy Agrees to Terms on $8 Million Option Agreement With Inspiration Energy for Plateau and Ledge Properties24.4.2024 13:00:00 CEST | Press release
HIGHLIGHTS Option provides Inspiration Energy an opportunity to acquire a 70% interest in each of ATHA’s early-stage Plateau Property (27,252 Ha) and Ledge Property (37,784 Ha), located in the Athabasca Basin, by fulfilling a total of $8 million in exploration expenditures on the properties: Plateau: Inspiration must incur a total of $3.8 million in eligible exploration expenses between closing of the agreement and September 1, 2028 Ledge: Inspiration must incur a total of $4.2 million in eligible exploration expenses between closing of the agreement and September 1, 2028 Within two days following regulatory approval, Inspiration Energy shall issue 4,330,228 Inspiration Energy Corp common shares to ATHA ATHA is entitled to anti-dilution rights such that shares issued shall be adjusted upwards to maintain a 9.0% ownership position in Inspiration Energy during the option period VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (TSX.V: SASK) (FRA: X5U) (OTC
Aduro Clean Technologies Joins Delegation at Intergovernmental Negotiating Committee on Plastic Pollution (INC-4)24.4.2024 13:00:00 CEST | Press release
LONDON, Ontario, April 24, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is joining a delegation of observers from civil society, environmental groups, academics and business at the fourth meeting of the Intergovernmental Negotiating Committee on Plastic Pollution (INC-4) in Ottawa, Ontario, Canada from April 23rd to 29th, 2024. INC-4 welcomes over 4,200 delegates, including 1,400 government members and 2,800 observers, who will discuss a draft treaty prepared after the third meeting of the INC. This draft serves as a basis for negotiations, aiming to finalize an agreement that encompasses various aspects of plastic management such as design, waste management, extended producer responsibility, and capacity building, especially
Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases24.4.2024 13:00:00 CEST | Press release
Program is the Product of a Research Collaboration between Biolojic Design and Nektar entered in 2021 TEL AVIV, Israel and SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Biolojic Design, a biotechnology company that uses AI to transform antibodies into intelligent medicinal solutions, today announced that Nektar exercised its license option to develop a program resulting from the companies’ research collaboration initiated in 2021. The research collaboration was established to design and test agonistic antibodies targeting tumor necrosis factor receptor type II (TNFR2), a novel, biologically-validated disease target implicated in a wide range of autoimmune diseases that has been difficult to drug with conventional medicines. The antibody program selected for development (now known as NKTR-0165) is designed to modulate the TNFR2 pathway in order to agonize - or activate - T regulatory cells and other anti-inflammatory cell populations, making this a promising approach to stimulating